Progressive Care Expands Its Corporate Services with Enhanced COVID-19 Platform Capabilities
February 16 2022 - 7:23AM
InvestorsHub NewsWire
Ability to Schedule On-site
Testing, Pay and Receive Results Online Within Minutes
MIAMI, FL -- February 16, 2022 -- InvestorsHub NewsWire --
Progressive Care Inc. (OTCQB:
RXMD) (the “Company”), a personalized healthcare services and
technology provider, is pleased to announce its expansion into
corporate-focused services with enhanced technological capabilities
to help businesses manage COVID-19 testing and vaccination in the
workplace.
Progressive Care’s PharmcoRx.com platform now allows business
managers or their appointed administrators to schedule COVID-19
testing for large groups online, select a preferred testing
location or request an on-site visit, receive and securely share
their employees’ testing results, as well as securely communicate
with the pharmacy’s lab staff in real-time.
Carlos Rangel, Head of Digital Transformation of Progressive
Care, stated, “We have been able to provide our institutional
clients with a complete platform for COVID-19 management in the
workplace including the performance of on-site testing and
vaccinations with real-time reporting through our patient portal.
We look forward to continuing to build strong relationships in the
corporate space and we are excited about our technology
capabilities.”
Due to the latest COVID-19 surge, organizations are turning to
companies such as Progressive Care for COVID-19 management
solutions that provide COVID-19 PCR and Antigen test results within
15 to 30 minutes. The Company’s COVID-19 team has established
working relationships with top entertainment and media production
companies in the United States, large manufacturers, embassies, and
Fortune 500 companies. Progressive Care currently operates over 40
COVID-19 rapid PCR test analyzers and has generated over $4 million
in testing revenue in 2021. Its online COVID-19 platform comes as
the preface of a more comprehensive initiative to bring rapid
COVID-19 point of care PCR testing nationwide.
Alan Jay Weisberg, CEO and Chairman of the Board, added,
“Despite adverse labor conditions and ongoing challenges brought by
COVID-19 variants, our team of dedicated professionals was able to
successfully deliver on our mission to protect workplaces through
the continued development of our digital platform capabilities to
stay at the vanguard of healthcare technology.”
Progressive Care, Inc.
Progressive Care, Inc. (OTCQB:
RXMD), through its subsidiaries, is a Florida health services
organization and provider of prescription pharmaceuticals,
compounded medications, provider of tele-pharmacy services, the
sale of anti-retroviral medications, medication therapy management
(MTM), the supply of prescription medications to long-term care
facilities, and health practice risk management.
For more information about Progressive Care, please visit the
company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.progressivecareus.com/
https://twitter.com/ProgressCareUS
PharmCoRx
https://www.pharmcorx.com/
https://twitter.com/PharmCoRx
ClearMetrX
https://www.clearmetrx.com/
https://www.facebook.com/clearmetrx/
Forward-Looking Statements:
Statements contained herein that are not based upon current or
historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such forward-looking statements reflect the Company’s
expectations about its future operating results, performance, and
opportunities that involve substantial risks and uncertainties.
When used herein, the words “anticipate,” “believe,” “estimate,”
“upcoming,” “plan,” “target,” “intend” and “expect” and similar
expressions, as they relate to Progressive Care Inc., its
subsidiaries, or its management, are intended to identify such
forward-looking statements. These forward-looking statements are
based on information currently available to the Company and are
subject to a number of risks, uncertainties, and other factors that
could cause the Company’s actual results, performance, prospects,
and opportunities to differ materially from those expressed in, or
implied by, these forward-looking statements.
Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com
Investor Relations Contact:
ClearThink Capital
nyc@clearthink.capital
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Sep 2023 to Sep 2024